Abstract
Bisphosphonates (BPs) are antiresorptive drugs used in the treatment of lytic bone diseases. Among its adverse effects is the medication-related osteonecrosis of the jaw (MRONJ). Studies show that among the risk factors for MRONJ are: advanced age, female gender, use of oncologic doses of potent BPs and invasive dental procedures. The etiopathogenesis of MRONJ is poorly understood, making…